Identifying Patients With Inflammatory Bowel Diseases in an Administrative Health Claims Database: Do Algorithms Generate Similar Findings?

被引:5
|
作者
Ye, Yizhou [1 ]
Manne, Sudhakar [1 ]
Bennett, Dimitri [1 ,2 ]
机构
[1] Takeda Pharmaceut Co Ltd, Cambridge, MA USA
[2] Univ Penn, Philadelphia, PA 19104 USA
关键词
administrative claims database; Crohn's disease; inflammatory bowel diseases; observational study; retrospective studies; ulcerative colitis; REAL-WORLD EVIDENCE; ULCERATIVE-COLITIS; CROHNS-DISEASE; PREVALENCE; CANCER; CARE; VALIDATION; BREAST;
D O I
10.1177/0046958019887816
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Application of selective algorithms to administrative health claims databases allows detection of specific patients and disease or treatment outcomes. This study identified and applied different algorithms to a single data set to compare the numbers of patients with different inflammatory bowel disease classifications identified by each algorithm. A literature review was performed to identify algorithms developed to define inflammatory bowel disease patients, including ulcerative colitis, Crohn's disease, and inflammatory bowel disease unspecified in routinely collected administrative claims databases. Based on the study population, validation methods, and results, selected algorithms were applied to the Optum Clinformatics (R) Data Mart database from June 2000 to March 2017. The patient cohorts identified by each algorithm were compared. Three different algorithms were identified from literature review and selected for comparison (A, B, and C). Each identified different numbers of patients with any form of inflammatory bowel disease (323 833; 246 953, and 171 537 patients, respectively). The proportions of patients with ulcerative colitis, Crohn's disease, and inflammatory bowel disease unspecified were 32.0% to 47.5%, 38.6% to 43.8%, and 8.7% to 26.6% of the total population with inflammatory bowel disease, respectively, depending on the algorithm applied. Only 5.1% of patients with inflammatory bowel disease unspecified were identified by all 3 algorithms. Algorithm C identified the smallest cohort for each disease category except inflammatory bowel disease unspecified. This study is the first to compare numbers of inflammatory bowel disease patients identified by different algorithms from a single database. The differences between results highlight the need for validation of algorithms to accurately identify inflammatory bowel disease patients.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Identifying Patients with Group 3 Pulmonary Hypertension Associated with COPD or ILD Using an Administrative Claims Database
    Gustavo A. Heresi
    Bonnie B. Dean
    Howard Castillo
    Henry F. Lee
    Peter Classi
    Dana Stafkey-Mailey
    Alexander Kantorovich
    Kellie Morland
    Margaret R. Sketch
    Benjamin S. Wu
    Christopher S. King
    [J]. Lung, 2022, 200 : 187 - 203
  • [22] Identifying chronic disease patients using predictive algorithms in pharmacy administrative claims: an application in rheumatoid arthritis
    Hernandez, Ervant J. Maksabedian
    Tingzon, Isabelle
    Ampil, Lorenzo
    Tiu, Jessica
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 1272 - 1279
  • [23] Use of algorithms for identifying patients in a German claims database: learnings from a lung cancer case
    Sina Neugebauer
    Frank Griesinger
    Sabine Dippel
    Stephanie Heidenreich
    Nina Gruber
    Detlef Chruscz
    Sebastian Lempfert
    Peter Kaskel
    [J]. BMC Health Services Research, 22
  • [24] Use of algorithms for identifying patients in a German claims database: learnings from a lung cancer case
    Neugebauer, Sina
    Griesinger, Frank
    Dippel, Sabine
    Heidenreich, Stephanie
    Gruber, Nina
    Chruscz, Detlef
    Lempfert, Sebastian
    Kaskel, Peter
    [J]. BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [25] Disease severity in the INFLAMMATORY BOWEL DISEASES: Do patients and physicians agree?
    Timmer, A.
    de Sordi, D.
    Neuser, J.
    Seibel, K.
    Hensel, A.
    Schmidt-Lauber, M.
    Allgayer, H.
    Klebl, F.
    Obermeier, F.
    Jessen, P.
    Schnoy, E.
    Helwig, U.
    Morgenstern, J.
    Leifeld, L.
    Schmidt, S.
    Meinhardt, C.
    Maaser, C.
    Bastlein, E.
    Bokemeyer, A.
    Graefe, U.
    Kuehbacher, T.
    Kaltz, B.
    Sander, C.
    Wolfgang, K.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I524 - I525
  • [26] Disease severity in the INFLAMMATORY BOWEL DISEASES: Do patients and physicians agree?
    Timmer, A.
    de Sordi, D.
    Neuser, J.
    Seibel, K.
    Hensel, A.
    Schmidt-Lauber, M.
    Allgayer, H.
    Klebl, F.
    Obermeier, F.
    Jessen, P.
    Schnoy, E.
    Helwig, U.
    Morgenstern, J.
    Leifeld, L.
    Schmidt, S.
    Meinhardt, C.
    Maaser, C.
    Baestlein, E.
    Bokemeyer, A.
    Graefe, U.
    Kuhbacher, T.
    Kaltz, B.
    Sander, C.
    Wolfgang, K.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I524 - I525
  • [27] A Commentary to "The prevalence of hypertensive diseases and treated hypertensive patients in Japan: a nationwide administrative claims database study"
    Park, Sungha
    [J]. HYPERTENSION RESEARCH, 2022, 45 (08) : 1274 - 1275
  • [28] Identifying Patients With Inflammatory Bowel Diseases at High vs Low Risk of Complications
    Siegel, Corey A.
    Bernstein, Charles N.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (06) : 1261 - 1267
  • [29] A Commentary to “The prevalence of hypertensive diseases and treated hypertensive patients in Japan: a nationwide administrative claims database study”
    Sungha Park
    [J]. Hypertension Research, 2022, 45 : 1274 - 1275
  • [30] Prevalence of Inflammatory Bowel Diseases in Puerto Rico: A Health Care Claims Analysis of an Insured Population
    Torres, Esther A.
    Torres-Cintron, Mariela
    Velazquez, Stephanie
    Vendrell, Roberto
    del Valle, Antonio
    Perez, Cynthia M.
    [J]. PUERTO RICO HEALTH SCIENCES JOURNAL, 2021, 40 (03) : 103 - 109